Clinical Trial Update: Histidine-Tryptophane-Ketoglutarate (HTK) vs University of Wisconsin (UW) Perfusion in Clinical Pancreas Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Histidine-Tryptophan-Ketoglutarate (HTK) solution versus UW Perfusion in pancreas transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Pancreas Transplantation

Drugs mentioned

• Histidine-Tryptophan-Ketoglutarate (HTK) solution (Histidine-tryptophan-ketoglutarate solution)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Diabetes Mellitus, Pancreas Transplantation | Phase 4 | Status: COMPLETED